Abstract | BACKGROUND: OBJECTIVE: METHODS: In a double-blind randomized prospective study, 50 patients with allergic rhinitis and 10 with nasal polyposis received intranasal illumination at 660 nm for 4.4 minutes three times a day for 14 days (total dose 6 joules per day). Twenty-nine rhinitic patients and one patient with polyposis received equivalent sham illumination as placebo. Evaluation was based on symptom scores and a clinical assessment that included pre-treatment and post-treatment videotaped rigid and flexible nasendoscopy. RESULTS: Following treatment, improvement of symptoms was reported by 72% of the allergic rhinitis patients and objective improvement was endoscopically demonstrated in 70% of them as compared with 24% and 3%, respectively, in the placebo group. These differences were significant. No improvement was obtained in any of the patients with polyposis. CONCLUSIONS:
Allergic rhinitis, if uncomplicated by polyps or chronic sinusitis, can be effectively treated by narrow-band red light illumination of the nasal mucosa at 660 nm, with marked alleviation of clinical symptoms. Whenever possible, candidates for phototherapy should be selected by endoscopic examination.
|
Authors | I Neuman, Y Finkelstein |
Journal | Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
(Ann Allergy Asthma Immunol)
Vol. 78
Issue 4
Pg. 399-406
(Apr 1997)
ISSN: 1081-1206 [Print] United States |
PMID | 9109708
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Topics |
- Adolescent
- Adult
- Aged
- Asthma
(therapy)
- Child
- Double-Blind Method
- Endoscopy
(methods)
- Female
- Humans
- Male
- Middle Aged
- Nasal Obstruction
(therapy)
- Nasal Polyps
(therapy)
- Phototherapy
- Rhinitis, Allergic, Perennial
(therapy)
- Video Recording
|